ArticleBlood2018

Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.

Silvia Maifrede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.